Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Vaccinations01:51

Vaccinations

46.3K
Overview
46.3K
Cancer Vaccines01:30

Cancer Vaccines

562
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
562
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

496
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
496
Development of Immunocompetence01:22

Development of Immunocompetence

516
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
516
Cross-reactivity00:42

Cross-reactivity

31.8K
Overview
31.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The United States is driving a public health emergency of international concern.

BMJ (Clinical research ed.)·2026
Same author

WHO Pandemic Agreement is only the beginning: strengthening implementation to protect global health.

BMJ (Clinical research ed.)·2026
Same author

In vivo base editing reduces liver cysts in autosomal dominant polycystic kidney disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Law and power in pandemic negotiations: Policymaking via contract in South Africa's dealings with COVID-19 vaccine companies.

Global public health·2025
Same author

Valosin-containing protein in ciliary morphology: a novel target in ADPKD.

American journal of physiology. Renal physiology·2025
Same author

Law and Global Governance of Infectious Disease: Access to Medicines on COVID-19, AIDS, and Beyond.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2025
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
関連記事をすべて見る

関連する実験動画

Updated: Oct 16, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.2K

ワクチンに関するノウハウの共有

Priti Krishtel1, Fatima Hassan2

  • 1Priti Krishtel is a founder and an executive director of the Initiative for Medicines, Access and Knowledge, Oakland, CA, USA.

Science (New York, N.Y.)
|October 21, 2021
PubMed
まとめ
この要約は機械生成です。

ローマで開催されるG20サミットでは,COVID-19ワクチンの供給を増やすことに焦点を当てて,世界の課題に取り組む予定です. ワクチンの不平等に対処することは 将来の世界的な健康危機に対処するために 極めて重要です

科学分野:

  • 世界保健
  • 経済学
  • ワクチン学

背景:

  • 世界のGDPの80%を代表するG20は,重要な国際問題を議論するために集まります.
  • 重要な議題は,世界規模のCOVID-19ワクチンの供給拡大の緊急性です.

さらに関連する動画

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.1K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K

関連する実験動画

Last Updated: Oct 16, 2025

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.2K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.1K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K